Lamotrigine in bipolar disorder: Results of a mirror-image evaluation using the NIMH Lifechart-Methodology

Journal of Affective Disorders

Volumn 115, Issue 1-2, 2009, Pages 241-245

  Born, C ^a   Bernhard, B ^a   Dittmann, S ^a   Seemuller F ^a   Grunze, H ^a,b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Bipolar disorder; Depression; Lamotrigine; Lifechart Methodology; Mania

Indexed keywords

AMISULPRIDE; CARBAMAZEPINE; CITALOPRAM; CLOZAPINE; DOXEPIN; FLUOXETINE; FLUVOXAMINE; LAMOTRIGINE; LITHIUM; MIRTAZAPINE; OLANZAPINE; PAROXETINE; PERAZINE; REBOXETINE; RISPERIDONE; SERTRALINE; THIORIDAZINE; TOPIRAMATE; VALPROIC ACID; VENLAFAXINE;

ADULT; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BIPOLAR MANIA; CHEMOPROPHYLAXIS; CLINICAL ASSESSMENT TOOL; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIFECHART; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIXED MANIA AND DEPRESSION; NATURALISTIC INQUIRY; OUTPATIENT CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RATING SCALE; RETROSPECTIVE STUDY; TREATMENT OUTCOME; YOUNG MANIA RATING SCALE;

ADULT; AFFECT; ANTICONVULSANTS; BIPOLAR DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GERMANY; HUMANS; LIFE TABLES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; RETROSPECTIVE STUDIES; TRIAZINES; YOUNG ADULT;

EID: 62649137056     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2008.07.020     Document Type: Article

References (26)

1. Angst J. The emerging epidemiology of hypomania and bipolar II disorder. J. Affect. Disord. 50 2-3 (1998) 143-151
2. Angst J., Merikangas K., Scheidegger P., and Wicki W. Recurrent brief depression: a new subtype of affective disorder. J. Affect. Disord. 19 2 (1990) 87-98
3. Bowden C.L., Calabrese J.R., Wallin B.A., Swann A.C., McElroy S.L., Risch S.C., and Hirschfeld R.M. Who enters therapeutic trials?. Psychopharmacol. Bull. 31 (1995) 103-109
4. Bowden C.L., Calabrese J.R., Sachs G., Yatham L.N., Asghar S.A., Hompland M., Montgomery P., Earl N., Smoot T.M., and DeVeaugh-Geiss J. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch. Gen. Psychiatry 60 4 (2003) 392-400
5. Brodie M.J., Richens A., and Yuen A.W. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK lamotrigine/carbamazepine monotherapy trial group. Lancet 345 8948 (1995) 476-479
6. Calabrese J.R., Rapport D.J., Shelton M.D., Kujawa M., and Kimmel S.E. Clinical studies on the use of lamotrigine in bipolar disorder. Neuropsychobiology 38 3 (1998) 185-191
7. Calabrese J.R., Bowden C.L., Sachs G.S., Ascher J.A., Monaghan E., and Rudd G.D. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 study group. J. Clin. Psychiatry 60 2 (1999) 79-88
8. Calabrese J.R., Suppes T., Bowden C.L., Sachs G.S., Swann A.C., McElroy S.L., Kusumakar V., Ascher J.A., Earl N.L., Greene P.L., and Monaghan E.T. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 study group. J. Clin. Psychiatry 61 11 (2000) 841-850
9. Calabrese J.R., Vieta E., and Shelton M.D. Latest maintenance data on lamotrigine in bipolar disorder. Eur. Neuropsychopharmacol. 13 Suppl 2 (2003) 57-66 57-66
10. Denicoff K.D., Smith-Jackson E.E., Disney E.R., Suddath R.L., Leverich G.S., and Post R.M. Preliminary evidence of the reliability and validity of the prospective life-chart methodology (LCM-p). J. Psychiatr. Res. 31 5 (1997) 593-603
11. Denicoff K.D., Leverich G.S., Nolen W.A., Rush A.J., McElroy S.L., Keck P.E., Suppes T., Altshuler L.L., Kupka R., Frye M.A., Hatef J., Brotman M.A., and Post R.M. Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM-p) for longitudinal assessment of bipolar illness. Psychol. Med. 30 6 (2000) 1391-1397
12. Dittmann S., Biedermann N.C., Grunze H., Hummel B., Scharer L.O., Kleindienst N., Forsthoff A., Matzner N., Walser S., and Walden J. The Stanley Foundation Bipolar Network: results of the naturalistic follow-up study after 2.5 years of follow-up in the German centres. Neuropsychobiology 46 Suppl 1 (2002) 2-9 2-9
13. Fatemi S.H., Rapport D.J., Calabrese J.R., and Thuras P. Lamotrigine in rapid-cycling bipolar disorder. J. Clin. Psychiatry 58 12 (1997) 522-527
14. Frye M.A., Ketter T.A., Kimbrell T.A., Dunn R.T., Speer A.M., Osuch E.A., Luckenbaugh D.A., Cora-Ocatelli G., Leverich G.S., and Post R.M. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J. Clin. Psychopharmacol. 20 6 (2000) 607-614
15. Ketter T.A., and Calabrese J.R. Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclature. J. Clin. Psychiatry 63 2 (2002) 146-151
16. Ketter T.A., Manji H.K., and Post R.M. Potential mechanisms of action of lamotrigine in the treatment of bipolar disorders. J. Clin. Psychopharmacol. 23 5 (2003) 484-495
17. Kusumakar V., and Yatham L.N. An open study of lamotrigine in refractory bipolar depression. Psychiatry Res. 72 2 (1997) 145-148 %19
18. Leverich G.S., Nolen W.A., Rush A.J., McElroy S.L., Keck J., Denicoff K.D., Suppes T., Altshuler L.L., and Kupka R. The Stanley Foundation Bipolar Treatment Outcome Network: I. longitudinal methodology. J. Affect. Disord. 67 1-3 (2001) 33-44
19. Matsuo F. Lamotrigine. Epilepsia 40 Suppl 5 (1999) S30-S36
20. Muzina D.J., El Sayegh S., and Calabrese J.R. Antiepileptic drugs in psychiatry - focus on randomized controlled trial. Epilepsy Res. 50 1-2 (2002) 195-202
21. Post R.M., Roy-Byrne P.P., and Uhde T.W. Graphic representation of the life course of illness in patients with affective disorder. Am. J. Psychiatry 145 7 (1988) 844-848
22. Rush A.J., Giles D.E., Schlesser M.A., Fulton C.L., Weissenburger J., and Burns C. The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res. 18 1 (1986) 65-87
23. Smith D., Baker G., Davies G., Dewey M., and Chadwick D.W. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 34 2 (1993) 312-322
24. Spearing M.K., Post R.M., Leverich G.S., Brandt D., and Nolen W. Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res. 73 3 (1997) 159-171
25. Walden J., Hesslinger B., van Calker D., and Berger M. Addition of lamotrigine to valproate may enhance efficacy in the treatment of bipolar affective disorder. Pharmacopsychiatry 29 5 (1996) 193-195
26. Young R.C., Biggs J.T., Ziegler V.E., and Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 133 (1978) 429-435 429-435